Home NDC 21695-059 GABAPENTIN
Product NDC 21695-059
11-digit product format 216950059
Labeler code 21695
Product ID 21695-059_95ceac2d-ce96-4d9d-9fe6-893940f1decb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name GABAPENTIN
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Rebel Distributors Corp.
Application ANDA077525
Marketing category ANDA
Marketing start 2006-08-24
Marketing end 0000-00-00
Substance GABAPENTIN
Active strength 800 mg/1
Pharmacologic classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 2 of 2 · 88 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077525-001 GABAPENTIN GABAPENTIN 600MG TABLET / ORAL 2006-08-24 A077525-002 GABAPENTIN GABAPENTIN 800MG TABLET / ORAL 2006-08-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB1 2006-08-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB1 2006-08-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077525-001 GABAPENTIN 600MG TABLET / ORAL 2006-08-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077525-002 GABAPENTIN 800MG TABLET / ORAL 2006-08-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB1 2006-08-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB1 2006-08-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB1 2006-08-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB1 2006-08-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB1 2006-08-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB1 2006-08-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB1 2006-08-24 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB1 2006-08-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB1 2006-08-24 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB1 2006-08-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB 2006-08-24 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB 2006-08-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB 2006-08-24 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB 2006-08-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB 2006-08-24 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB 2006-08-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A077525-001 GABAPENTIN 600MG TABLET / ORAL AB 2006-08-24 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A077525-002 GABAPENTIN 800MG TABLET / ORAL AB 2006-08-24 74a2ff9319b5…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 64 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 21695-059-30 GABAPENTIN 30 in 1 BOTTLE TABLET, FILM COATED 30 1 21695-059-60 GABAPENTIN 60 in 1 BOTTLE TABLET, FILM COATED 60 1 21695-059-90 GABAPENTIN 90 in 1 BOTTLE TABLET, FILM COATED 90 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded GABAPENTIN ACTIVE INGREDIENT 6CW7F3G59X GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 GABAPENTIN ACTIVE MOIETY 6CW7F3G59X GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 GLYCERYL BEHENATE INACTIVE INGREDIENT R8WTH25YS2 GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 HYDROXYPROPYL CELLULOSE INACTIVE INGREDIENT RFW2ET671P GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED INACTIVE INGREDIENT 2165RE0K14 GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 HYPROMELLOSE INACTIVE INGREDIENT 3NXW29V3WO GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 MANNITOL INACTIVE INGREDIENT 3OWL53L36A GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 TALC INACTIVE INGREDIENT 7SEV7J4R1U GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 21695-059 GABAPENTIN (GABAPENTIN) TABLET, FILM COATED [REBEL DISTRIBUTORS CORP.] 1 Legacy NDC, 3 package rows 20091208_2fe659eb-a8b4-491b-9195-fe979d7f0373.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 21695-059-30 21695005930 30 in 1 BOTTLE Historical 21695-059-60 21695005960 60 in 1 BOTTLE Historical 21695-059-90 21695005990 90 in 1 BOTTLE Historical